💉 TD Cowen kept a Hold rating on Merck despite Wednesday’s news that its cancer vaccine succeeded in a large clinical trial, tempering some of this week’s pharma optimism.
💉 TD Cowen kept a Hold rating on Merck despite Wednesday’s news that its cancer vaccine succeeded in a large clinical trial, tempering some of this week’s pharma optimism.